Updates are available Correction dated 2022-03-07
Click to view Correction: https://doi.org/10.1186/s42494-022-00081-5
-
Authors
Ye, Yuanzhen
Sun, Dan
Li, Hua
Zhong, Jianmin
Luo, Rong
Li, Baomin
Zhu, Dengna
Li, Dan
Huang, Shaoping
Jiang, Yuwu
Xiao, Nong
Chen, Yucai
Zhang, Yuqin
Yu, Mei
Shen, Xiaoyun
Gao, Li
Zheng, Guo
Zhao, Congmin
Yuan, Baoqiang
Liao, Jianxiang https://orcid.org/0000-0001-9769-3365
Qin, Jiong
,
-
Funding
Funding for this research was provided by:
Sanming Project of Medicine in Shenzhen (SZSM201812005)
Shenzhen Key Medical Discipline Construction Fund (No.SZXK033)
Shenzhen Fund for Guangdong Provincial High Level Clinical Key Specialties (No.SZGSP012)
- License Information
-
More Information
Article History
Received: 7 September 2021
Accepted: 19 December 2021
First Online: 15 February 2022
Change Date: 7 March 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s42494-022-00081-5
Declarations
:
: This study was approved by the Medical Ethics Committee of Shenzhen Children’s Hospital, with a Clinical trial registration No. of ChiCTR-IIR-16008342. Informed consent was obtained from all patients in this study.
: Not applicable.
: Author JQ is the editorial board member for Acta Epileptologica. Author JQ was not involved in the journal’s review of, or decisions related to this manuscript. JX L is a consultant of Shenzhen Zeneca Biotechnology Co., LTD. Shenzhen, China.
